IO Biotech (IOBT) Stock Price

IO Biotech Price

CLOSED
0.00
​
Market closed

IO Biotech stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

IO Biotech business model & stock analysis

IO Biotech Inc, based in Copenhagen, Denmark, operates in the Health Care sector, specializing in Biotechnology. The company develops immune modulating cancer therapies using its T-win technology platform, focusing on disrupting tumor-induced immunosuppression. Its lead product candidate, IO102-IO103, targets immunosuppressive proteins like IDO and PD-L1. Founded as a spin-off from the National Cancer Center Immune Therapy at Herlev University Hospital, IO Biotech has 57 employees and is listed on the stock exchange since November 5, 2021.

Frequently asked questions about IO Biotech

10 analysts currently rate the IO Biotech stock: 1 recommend buying, 5 holding and 4 selling.

Converted at the current exchange rate, the IO Biotech share trades at 0.00 EUR (0.00 USD).

The revenue cannot currently be calculated for IO Biotech.

The expected profit of IO Biotech is -25.90 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of IO Biotech is currently -0.00. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the IO Biotech stock.

The P/S cannot be calculated for IO Biotech currently.

The Eulerpool Quality Score for IO Biotech is 2/10.

The ISIN of IO Biotech is US4497781090. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of IO Biotech is IOBT. The ticker symbol is used to trade IO Biotech shares on the stock exchange.

Fair ValueTerminal
0.00 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Denmark
Currency
USD
Initial public offering
Nov 5, 2021
ISIN
US4497781090
Cusip
449778109
Market capitalization
14,390.00 USDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2025
-0.00
P/Ee 2026
-0.00
P/Ee 2027
-0.00
P/Ee 2028
-0.00
P/Ee 2029
0.00
P/S
P/Se
—
EV/EBIT
1.24
P/B Ratio
0.00
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-195.16 %
Last updated Oct 18, 2026, 3:06 AM

IO Biotech Peer Group

IO Biotech FIGI

IOBT:US · BBG0131XRY31IOBT:UA · BBG0131XRY40IOBT:UC · BBG0131XRY59IOBT:UN · BBG0131XRY77IOBT:UP · BBG0131XRY86IOBT:UB · BBG0131XRYB2IOBT:UM · BBG0131XRYD0IOBT:UX · BBG0131XRYF8IOBT:UD · BBG0131XRYL1IOBT:UW · BBG0131XRYN9IOBT:UF · BBG0131XRYP7IOBT:VY · BBG0131XRYQ6

All fundamentals and in-depth analysis of IO Biotech

Our stock analysis for IO Biotech stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of IO Biotech. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.